(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANÁLOGOS DE THR BETA E USOS DOS MESMOS

Em AnáliseInvention PatentPCT · US2023062351

Application data

Number

112024016378

Type

Invention Patent

Filing

02/10/2023

Publication

11/26/2024

PCT

US2023062351

Progress at the INPI

  1. Filing02/10/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 02/10/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/26/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MADRIGAL PHARMACEUTICALS, INC.

US

Inventors

J. H. (pessoa física)

US

P. C. (pessoa física)

US

Technical data

Priority claims

US

63/308,709 · 02/10/2022

US

63/419,790 · 10/27/2022

Abstract

ANÁLOGOS DE THR BETA E USOS DOS MESMOS. A presente invenção refere-se a compostos de fórmula I e sais, solvatos, e estereoisômeros farmaceuticamente aceitáveis dos mesmos, e seus usos como ativadores do receptor de hormônio da tireoide (THR) ß.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

11/26/2024

RPI 2812

Alteração de dados cadastrais

#1.1

08/20/2024

RPI 2798

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.